Next Article in Journal
Updated Values for Molecular Diagnosis for Highly Pathogenic Avian Influenza Virus
Next Article in Special Issue
Construction of a High Titer Infectious HIV-1 Subtype C Proviral Clone from South Africa
Previous Article in Journal
Evaluation of the Operator Protection Factors Offered by Positive Pressure Air Suits against Airborne Microbiological Challenge
Previous Article in Special Issue
Mining the Protein Data Bank to Differentiate Error from Structural Variation in Clustered Static Structures: An Examination of HIV Protease
Article Menu

Export Article

Open AccessArticle
Viruses 2012, 4(8), 1212-1234; doi:10.3390/v4081212

Persistence versus Reversion of 3TC Resistance in HIV-1 Determine the Rate of Emergence of NVP Resistance

1
Center for AIDS Research, Division of Infectious Diseases and Geographic Medicine, Stanford University School of Medicine, Stanford, CA 94305, USA
2
Department of Pediatrics, Division of Pneumonology-Immunology, Charité University Medical Center, Berlin 13353, Germany
3
Division of Biostatistics, Stanford University School of Medicine, Stanford, CA 94305, USA
*
Author to whom correspondence should be addressed.
Received: 11 July 2012 / Revised: 3 August 2012 / Accepted: 6 August 2012 / Published: 7 August 2012
(This article belongs to the Special Issue HIV Dynamics and Evolution)
View Full-Text   |   Download PDF [390 KB, uploaded 12 May 2015]   |  

Abstract

When HIV-1 is exposed to lamivudine (3TC) at inhibitory concentrations, resistant variants carrying the reverse transcriptase (RT) substitution M184V emerge rapidly. This substitution confers high-level 3TC resistance and increased RT fidelity. We established a novel in vitro system to study the effect of starting nevirapine (NVP) in 3TC-resistant/NNRTI-naïve clinical isolates, and the impact of maintaining versus dropping 3TC pressure in this setting. Because M184V mutant HIV-1 seems hypersusceptible to adefovir (ADV), we also tested the effect of ADV pressure on the same isolates. We draw four conclusions from our experiments simulating combination therapy in vitro. (1) The presence of low-dose (1 μM) 3TC prevented reversal to wild-type from an M184V mutant background. (2) Adding low-dose 3TC in the presence of NVP delayed the selection of NVP-associated mutations. (3) The presence of ADV, in addition to NVP, led to more rapid reversal to wild-type at position 184 than NVP alone. (4) ADV plus NVP selected for greater numbers of mutations than NVP alone. Inference about the “selection of mutation” is based on two statistical models, one at the viral level, more telling, and the other at the level of predominance of mutation within a population. Multidrug pressure experiments lend understanding to mechanisms of HIV resistance as they bear upon new treatment strategies. View Full-Text
Keywords: HIV-1; lamivudine; nevirapine; adefovir; resistance; selection; serial passage HIV-1; lamivudine; nevirapine; adefovir; resistance; selection; serial passage
Figures

This is an open access article distributed under the Creative Commons Attribution License (CC BY 3.0).

Scifeed alert for new publications

Never miss any articles matching your research from any publisher
  • Get alerts for new papers matching your research
  • Find out the new papers from selected authors
  • Updated daily for 49'000+ journals and 6000+ publishers
  • Define your Scifeed now

SciFeed Share & Cite This Article

MDPI and ACS Style

Rath, B.A.; Olshen, R.A.; Halpern, J.; Merigan, T.C. Persistence versus Reversion of 3TC Resistance in HIV-1 Determine the Rate of Emergence of NVP Resistance. Viruses 2012, 4, 1212-1234.

Show more citation formats Show less citations formats

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Viruses EISSN 1999-4915 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top